Employers May Follow Medicare Coverage Of GLP-1 Weight Loss Drugs

Contributing sentiments towards policy:

62% : "Our loved ones with Medicare deserve care that puts their interests first.
56% : "The Biden-Harris Administration has worked to ensure that the Medicare Advantage and Part D prescription drug programs work for people with Medicare, adopted policies holding plans accountable for providing high-quality health care, and protected the sustainability of the Medicare program," said CMS Administrator Chiquita Brooks-LaSure.
53% : "This proposed rule continues to build on this work by expanding access to anti-obesity medications for people with Medicare and Medicaid, further addressing prior authorization concerns in Medicare Advantage, and promoting informed choice and transparency by requiring Medicare Advantage plans to share provider directory information on Medicare Plan Finder.
51% : Costs would also rise for states that administer Medicaid coverage for the poor and Medicare, the health insurance program for the elderly, as well as private Medicare Advantage plans and Medicare Part D drug coverage, analysts say.
50% : "In recognition of the prevailing medical consensus that obesity is a disease, (the Centers for Medicare & Medicaid Services) is proposing to reinterpret the statute to no longer exclude anti-obesity medications for the treatment of obesity from coverage under Medicare Part D and to require Medicaid programs to cover these medications when used to treat obesity," CMS said in announcement its proposal.
46% : News the Biden administration plans to require Medicare and Medicaid government health insurance to cover weight loss drugs could trigger private employers to do the same for their obese employees.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.